- Home
- RLAY vs KRMD Comparison
RLAY vs KRMD Comparison
Compare RLAY & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | KRMD |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 198.3M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RLAY | KRMD |
|---|---|---|
| Price | $9.61 | $4.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $16.86 | $6.50 |
| AVG Volume (30 Days) | ★ 2.5M | 137.3K |
| Earning Date | 05-04-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.78 | ★ 53.85 |
| EPS | N/A | ★ N/A |
| Revenue | $15,355,000.00 | ★ $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | $324.03 | $17.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 53.44 | 22.23 |
| 52 Week Low | $1.78 | $1.87 |
| 52 Week High | $11.49 | $6.61 |
Technical Indicators
Market Signals| Indicator | RLAY | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 36.30 |
| Support Level | $9.06 | $4.08 |
| Resistance Level | $11.46 | $4.34 |
| Average True Range (ATR) | 0.63 | 0.20 |
| MACD | -0.12 | 0.02 |
| Stochastic Oscillator | 16.18 | 23.36 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).